Monday, 16 June 2014

Drug solid solutions – a method for tuning phase transformations

Drug solid solutions – a method for tuning phase transformations
Amit Delori, Pauline Maclure, Rajni M. Bhardwaj, Andrea Johnston, Alastair J. Florence, Oliver B. Sutcliffe and Iain D. H. Oswald
CrystEngComm, 2014, 16, 5827 DOI:10.1039/C4CE00211C
 
 This paper describes a methodology for the modification of phase transition temperatures using (±)-4′-methylmethcathinone solid solutions as an exemplar. This method serves to show that by varying the composition of the halide ion one can systematically alter the temperatures at which phase transitions can occur in order to evade the possibility of interconversion between polymorphs during processing or storage of materials.
 
 
 read at
 
 
 http://pubs.rsc.org/en/Content/ArticleLanding/2014/CE/C4CE00211C?utm_medium=email&utm_campaign=pub-CE-vol-16-issue-26&utm_source=toc-alert#!divAbstract

Drug solid solutions – a method for tuning phase transformations

*Corresponding authors
aStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, 161 Cathedral Street, Glasgow, UK G4 0RE
E-mail: iain.oswald@strath.ac.uk;
Fax: +44 (0)141 552 2562 ;
Tel: +44 (0)141 548 2157
bSchool of Science and the Environment, Manchester Metropolitan University, Chester Street, Manchester, UK M1 5GD
E-mail: o.sutcliffe@mmu.ac.uk;
Fax: +44 (0)161 2476840 ;
Tel: +44 (0)161 2471531
CrystEngComm, 2014,16, 5827-5831

DOI: 10.1039/C4CE00211C

Wednesday, 11 June 2014

Requirements for Process Validation of Biotech Active Pharmaceutical Ingredients (APIs)

 

Introduction
Process validation of Active Pharmaceuti-
cal Ingredients (APIs) is still one of the
most challenging topics for both pharma-
ceutical industry and regulatory authorities. It
is the clear expectation of regulatory authori-
ties, especially the FDA and EMEA, that pro-
duction processes, cleaning procedures, ana-
lytical methods, computer and utility systems
that have an impact on product quality and
purity are validated. Facilities and equipment
used in conjunction with production and testing
of APIs must be qualified. T
http://www.eurotherm-danmark.dk/medic/pharma_doc/press_release/ispe_reprint_process_validation.pdf

Tuesday, 10 June 2014

Inhibiting Protein Aggregation



Inhibiting Protein Aggregation

Conjugates of 8-hydroxyquinolines and cyclodextrins have been developed that function both as antioxidants and as metal chelators
Read more

The Biochemistry of Peppers – Part 2



The Biochemistry of Peppers – Part 2

We are only able to taste sweet, bitter, sour, salty, and umami – how do we taste hotness?
Read more

Friday, 30 May 2014

Cocrystals « New Drug Approvals

Cocrystals « New Drug Approvals:



'via Blog this'



ANTHONY MELVIN CRASTO
THANKS AND REGARD'S
DR ANTHONY MELVIN CRASTO Ph.D
amcrasto@gmail.com
MOBILE-+91 9323115463
GLENMARK SCIENTIST ,  INDIA
web link
http://anthonycrasto.jimdo.com/
Congratulations! Your presentation titled "Anthony Crasto Glenmark scientist, helping millions with websites" has just crossed MILLION views.
アンソニー     安东尼   Энтони    안토니     أنتوني
join my process development group on google
you can post articles and will be administered by me on the google group which is very popular across the world
LinkedIn group
 
blogs are
 
shark